TheraRadar
← Back
Data updated: Mar 29, 2026

ADARE PHARMS INC

CardiovascularNeurology
Generics

ADARE PHARMS INC is a generic drug manufacturer focused on Cardiovascular, Neurology.

2004
Since
3
Drugs
-
Trials
44
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PROPRANOLOL HYDROCHLORIDE 2026-01-27
POTASSIUM CHLORIDE 2025-12-22
POTASSIUM CHLORIDE 2025-11-20
POTASSIUM CHLORIDE 2025-10-27
Labeling
POTASSIUM CHLORIDE 2025-09-10
POTASSIUM CHLORIDE 2025-07-22
POTASSIUM CHLORIDE 2025-07-11
PROPRANOLOL HYDROCHLORIDE 2025-05-08
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
1 drugs
Neurology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GE HEALTHCARE specialty
Neurology, Cardiovascular
Novo Nordisk big-pharma
Cardiovascular, Neurology
LEDERLE big-pharma
Cardiovascular, Neurology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular
VALIDUS PHARMS specialty
Cardiovascular, Neurology